Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. (Q53330184)

13 May 2018

title

Use of a cytokine gene expression signature in lung adenocarcinoma and the surrounding tissue as a prognostic classifier. (English)

1 reference

13 May 2018

1 reference

10

Tatsuhiro Shibata

1 reference

13 May 2018

author name string

Masahiro Seike

1

1 reference

13 May 2018

Nozomu Yanaihara

2

1 reference

13 May 2018

Elise D Bowman

3

1 reference

13 May 2018

Krista A Zanetti

4

1 reference

13 May 2018

Anuradha Budhu

5

1 reference

13 May 2018

Kensuke Kumamoto

6

1 reference

13 May 2018

Leah E Mechanic

7

1 reference

13 May 2018

Shingo Matsumoto

8

1 reference

13 May 2018

Jun Yokota

9

1 reference

13 May 2018

Haruhiko Sugimura

11

1 reference

13 May 2018

Akihiko Gemma

12

1 reference

13 May 2018

Shoji Kudoh

13

1 reference

13 May 2018

Xin W Wang

14

1 reference

13 May 2018

Curtis C Harris

15

1 reference

13 May 2018

language of work or name

English

0 references

publication date

8 August 2007

1 reference

13 May 2018

Journal of the National Cancer Institute

published in

1 reference

13 May 2018

volume

99

1 reference

13 May 2018

issue

16

1 reference

13 May 2018

page(s)

1257-1269

1 reference

13 May 2018

Revisions in the International System for Staging Lung Cancer

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

A molecular signature of metastasis in primary solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Diversity of gene expression in adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Classification of human lung carcinomas by mRNA expression profiling reveals distinct adenocarcinoma subclasses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Prediction of lymph node metastasis by analysis of gene expression profiles in primary lung adenocarcinomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Genomic and proteomic profiling of lung cancers: lung cancer classification in the age of targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Identification of carboxypeptidase E and gamma-glutamyl hydrolase as biomarkers for pulmonary neuroendocrine tumors by cDNA microarray.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Unique microRNA molecular profiles in lung cancer diagnosis and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Predicting hepatitis B virus-positive metastatic hepatocellular carcinomas using gene expression profiling and supervised machine learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Prediction of venous metastases, recurrence, and prognosis in hepatocellular carcinoma based on a unique immune response signature of the liver microenvironment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Functional diversity of helper T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Distinct role of macrophages in different tumor microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Statistical significance of quantitative PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Diagnosis of multiple cancer types by shrunken centroids of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Quantitative analysis of Th1, Th2 and TGF-beta1 cytokine expression in tumor, TIL and PBL of non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Serum levels of interleukin 6 in patients with lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Small adenocarcinoma of the lung. Histologic characteristics and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Epidemiology of bronchioloalveolar carcinoma: improvement in survival after release of the 1999 WHO classification of lung tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Serum interleukin-10 levels as a prognostic factor in advanced non-small cell lung cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Expression profiles of non-small cell lung cancers on cDNA microarrays: identification of genes for prediction of lymph-node metastasis and sensitivity to anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Survival with mammary cancer related to the interaction of germinal center hyperplasia and sinus histiocytosis in axillary and internal mammary lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Gene expression predictors of breast cancer outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Autocrine and paracrine regulation of interleukin-8 expression in lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Cyclooxygenase-2-dependent expression of angiogenic CXC chemokines ENA-78/CXC Ligand (CXCL) 5 and interleukin-8/CXCL8 in human non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Interleukin-8/CXCL8 is a growth factor for human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

EGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

A randomized trial of adjuvant chemotherapy with uracil-tegafur for adenocarcinoma of the lung

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Vinorelbine plus cisplatin vs. observation in resected non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

Adjuvant vinorelbine plus cisplatin versus observation in patients with completely resected stage IB-IIIA non-small-cell lung cancer (Adjuvant Navelbine International Trialist Association [ANITA]): a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJM083

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJM083

1 reference

13 May 2018

release_d3tcvgdu2fh5hib3trj4cqug4i

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d3tcvgdu2fh5hib3trj4cqug4i

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

13 May 2018